Adelle E. Hamilton

Ms. Adelle E. Hamilton

Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, Alabama, USA
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2023 in Bioengineering
Verified
Journal Article
Open access
PDF file
Adelle E. HamiltonAdelle E. Hamilton
Adelle E. Hamilton
Ryan J. GilbertRyan J. Gilbert
Ryan J. Gilbert
Curcumin, a bioactive phenol derived from turmeric, is an antioxidant, anti-inflammatory, and antibacterial molecule. Although curcumin exhibits beneficial effects in its innate form, it is highly hydrophobic, which leads to poor water solubility and, consequently, low bioavailability. The lack of bioavailability limits curcumin’s effectiveness as a treatment and restricts its use in clinical applications. Furthermore, to achieve beneficial, clinically relevant results, high doses of curcumin are required for systemic administration. Many researchers have utilized biomaterial carriers, including electrospun fibers, nanoparticles, hydrogels, and composite scaffolds, to overcome curcumin’s principle therapeutic limitation of low bioavailability. By using biomaterials to deliver curcumin directly to injury sites, researchers have harnessed the beneficial natural properties of curcumin while providing scaffolding to support tissue regeneration. This review will provide an in-depth overview of the literature that utilizes biomaterial delivery of curcumin for tissue regeneration in injury and disease models.

24 October 2023 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
JSJayant Saksena
Jayant Saksena
Adelle E. HamiltonAdelle E. Hamilton
Adelle E. Hamilton
RGRyan J. Gilbert
Ryan J. Gilbert
JZJonathan M. Zuidema
Jonathan M. Zuidema
Central nervous system (CNS) glia, including astrocytes, microglia, and oligodendrocytes, play prominent roles in traumatic injury and degenerative disorders. Due to their importance, active pharmaceutical ingredients (APIs) are being developed to modulate CNS glia in order to improve outcomes in traumatic injury and disease. While many of these APIs show promise in vitro, the majority of APIs that are systemically delivered show little penetration through the blood–brain barrier (BBB) or blood-spinal cord barrier (BSCB) and into the CNS, rendering them ineffective. Novel nanomaterials are being developed to deliver APIs into the CNS to modulate glial responses and improve outcomes in injury and disease. Nanomaterials are attractive options as therapies for central nervous system protection and repair in degenerative disorders and traumatic injury due to their intrinsic capabilities in API delivery. Nanomaterials can improve API accumulation in the CNS by increasing permeation through the BBB of systemically delivered APIs, extending the timeline of API release, and interacting biophysically with CNS cell populations due to their mechanical properties and nanoscale architectures. In this review, we present the recent advances in the fields of both locally implanted nanomaterials and systemically administered nanoparticles developed for the delivery of APIs to the CNS that modulate glial activity as a strategy to improve outcomes in traumatic injury and disease. We identify current research gaps and discuss potential developments in the field that will continue to translate the use of glia-targeting nanomaterials to the clinic.

10 January 2025 in Journal of Neural Engineering
Verified
Journal Article
Closed access
Adelle E. HamiltonAdelle E. Hamilton
Adelle E. Hamilton
NWNikita Waskiewicz
Nikita Waskiewicz
GQGeraldine B Quinones
Geraldine B Quinones
JCJeffrey R. Capadona
Jeffrey R. Capadona
MBMarvin Bentley
Marvin Bentley
Ryan J. GilbertRyan J. Gilbert
Ryan J. Gilbert
Objective: Curcumin is an antioxidant and anti-inflammatory molecule that may provide neuroprotection following central nervous system (CNS) injury. However, curcumin is hydrophobic, limiting its ability to be loaded and then released from biomaterials for neural applications. We previously developed polymers containing curcumin, and these polymers may be applied to neuronal devices or to neural injury to promote neuroprotection. Thus, our objective was to evaluate two curcumin polymers as potential neuroprotective materials for neural applications. Approach: For each curcumin polymer, we created three polymer solutions by varying the weight percentage of curcumin polymer in solvent. These solutions were subsequently coated onto glass coverslips, and the thickness of the polymer was assessed using profilometry. Polymer degradation and dissolution was assessed using brightfield microscopy, scanning electron microscopy, and gel permeation chromatography. The ability of the polymers to protect cortical neurons from free radical insult was assessed using an in vitro cortical culture model. Main Results: The P50 curcumin polymer (containing greater poly(ethylene glycol) content than the P75 polymer), eroded readily in solution, with erosion dependent on the weight percentage of polymer in solvent. Unlike the P50 polymer, the P75 polymer did not undergo erosion. Since the P50 polymer underwent erosion, we expected that the P50 polymer would more readily protect cortical neurons from free radical insult. Unexpectedly, even though P75 films did not erode, P75 polymers protected neurons from free radical insult, suggesting that erosion is not necessary for these polymers to enable neuroprotection. Significance: This study is significant as it provides a framework to evaluate polymers for future neural applications. Additionally, we observed that some curcumin polymers do not require dissolution to enable neuroprotection. Future work will assess the ability of these materials to enable neuroprotection within in vivo models of neural injury.